Literature DB >> 28857905

Incidence of Cannula-Associated Deep Vein Thrombosis After Veno-Venous Extracorporeal Membrane Oxygenation.

Jay Menaker1, Ali Tabatabai, Raymond Rector, Katelyn Dolly, Joseph Kufera, Eugenia Lee, Zachary Kon, Pablo Sanchez, Si Pham, Daniel L Herr, Michael Mazzeffi, Ronald P Rabinowitz, James V O'Connor, Deborah M Stein, Thomas M Scalea.   

Abstract

Limited literature regarding the incidence of cannula-associated deep vein thrombosis (CaDVT) after veno-venous extracorporeal membrane oxygenation (VV ECMO) exists. The purpose of this study was to identify the incidence of post decannulation CaDVT and identify any associated risk factors. Forty-eight patients were admitted between August 2014 and January 2016 to the Lung Rescue Unit were included in the study. Protocolized anticoagulation levels (partial thromboplastin time [PTT] 45-55 seconds) and routine post decannulation DVT screening were in place during the study period. Forty-one (85.4%) patients had CaDVT. Of those with CaDVT, 31 (76%) patients were treated with full anti-coagulation therapy. Thirty-four (76%) patients with right internal jugular (RIJ) cannulation had CaDVT at cannula site. Twenty-five (61%) patients had CaDVT in the lower extremity (18 associated right femoral vein cannulation and 7 left femoral vein cannulation). Eighteen (44%) patients had both upper and lower extremity CaDVT. Overall, patients with CaDVT tended to be older, have a higher body mass index (BMI), and on ECMO longer (p = NS). Mean PTT during time on ECMO between patients that did and did not have CaDVT did not differ. No clinical evidence of pulmonary embolism (PE) was seen.

Entities:  

Mesh:

Year:  2017        PMID: 28857905     DOI: 10.1097/MAT.0000000000000539

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  15 in total

1.  Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) for Acute Respiratory Failure Following Injury: Outcomes in a High-Volume Adult Trauma Center with a Dedicated Unit for VV ECMO.

Authors:  Jay Menaker; Ronald B Tesoriero; Ali Tabatabai; Ronald P Rabinowitz; Christopher Cornachione; Terence Lonergan; Katelyn Dolly; Raymond Rector; James V O'Connor; Deborah M Stein; Thomas M Scalea
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

2.  Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis.

Authors:  Rafael S Cires-Drouet; Frederick Durham; Jashank Sharma; Praveen Cheeka; Zachary Strumpf; Erica Cranston; Cynthia Xu; Minerva Mayorga-Carlin; John D Sorkin; Brajesh K Lal
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2021-06-02

3.  Prevalence of Deep Vein Thrombosis in Patients Supported With Extracorporeal Membrane Oxygenation.

Authors:  Zo G S Vazquez; Neel R Sodha; Cynthia Devers; Corey E Ventetuolo; Adeel Abbasi
Journal:  ASAIO J       Date:  2021-10-01       Impact factor: 3.826

4.  Utilization of Thromboelastogram and Inflammatory Markers in the Management of Hypercoagulable State in Patients with COVID-19 Requiring ECMO Support.

Authors:  Angela Smolarz; Paul McCarthy; Aaron Shmookler; Vinay Badhwar; Awori J Hayanga; Ankit Sakhuja
Journal:  Case Rep Crit Care       Date:  2021-01-15

5.  Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.

Authors:  Mathieu Jozwiak; Jean-Daniel Chiche; Julien Charpentier; Zakaria Ait Hamou; Paul Jaubert; Sarah Benghanem; Pierre Dupland; Ariane Gavaud; Frédéric Péne; Alain Cariou; Jean-Paul Mira; Lee S Nguyen
Journal:  Front Med (Lausanne)       Date:  2020-12-10

6.  Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Joseph F Rappold; Forest R Sheppard; Samuel P Carmichael Ii; Joseph Cuschieri; Eric Ley; Erika Rangel; Anupamaa J Seshadri; Christopher P Michetti
Journal:  Trauma Surg Acute Care Open       Date:  2021-02-24

7.  Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis.

Authors:  Tia C L Kohs; Patricia Liu; Vikram Raghunathan; Ramin Amirsoltani; Michael Oakes; Owen J T McCarty; Sven R Olson; Luke Masha; David Zonies; Joseph J Shatzel
Journal:  Platelets       Date:  2021-08-06       Impact factor: 4.236

8.  Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.

Authors:  Gabriel Parzy; Florence Daviet; Basile Puech; Aude Sylvestre; Christophe Guervilly; Alizée Porto; Sami Hraiech; Kathia Chaumoitre; Laurent Papazian; Jean-Marie Forel
Journal:  Crit Care Med       Date:  2020-10       Impact factor: 9.296

Review 9.  A rational approach on the use of extracorporeal membrane oxygenation in severe hypoxemia: advanced technology is not a panacea.

Authors:  Dimitris Georgopoulos; Laurent Brochard; Evangelia Akoumianaki; Annemijn Jonkman; Michael C Sklar
Journal:  Ann Intensive Care       Date:  2021-07-12       Impact factor: 6.925

10.  The Venoarterial Extracorporeal Membrane Oxygenation Weaning Checklist.

Authors:  Maks Mihalj; Kent H Rehfeldt; Thierry Carrel; Frank Stueber; Markus M Luedi
Journal:  A A Pract       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.